Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00243_DB00701_nanopub.RAIiLEFnwxt60LO1pBMINB97fGpflI33nC_YwZqT6CJYY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00243_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00243_DB00701 label "DDI between Ranolazine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentratin of ranolazine by inhibiting its metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB00243_DB00701]" assertion.
- drugbank_resource:DB00243_DB00701 identifier "drugbank_resource:DB00243_DB00701" assertion.
- drugbank_resource:DB00243_DB00701 title "DDI between Ranolazine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentratin of ranolazine by inhibiting its metabolism. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00701 assertion.
- drugbank:DB00243 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00243_DB00701 assertion.